Enter to open, tab to navigate, enter to select
Teva Pharmaceutical Industries Ltd. tender offer for Auspex Pharmaceuticals, Inc.
| March 29, 2015 • Public Merger Agreements • $3.5 billion (equity value, or $3.2 billion enterprise value). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.